DeviceClearance

RABBITT ANTISERUM TO HUMAN C3C— 510(k) K831905

Substantially Equivalent

Dako Corp.

FDA 510(k) clearance K831905 for RABBITT ANTISERUM TO HUMAN C3C, Substantially Equivalent on 1983-07-18. Applicant: Dako Corp..

Clearance details

Applicant
Dako Corp.
Product code
Code CZW
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Mchenry, IL, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.